Marwan Sabbagh reports consulting for Corium, Eisai, Eli Lilly, KeifeRx, NeuroTherapia, Novo Nordisk, Prothena, Roche–Genentech, Signant Health, Synaptogenix, and T3D. Cristina Boschini, Magnus Fugger, Sune Dandanell, and Luis Rafael Solís Tarazona are employees and/or shareholders of Novo Nordisk A/S. Sharon Cohen is an employee of the Toronto Memory Program and has no financial conflicts of interest. Frank Jessen reports fees for advice and presentations for AC Immune, Biogen, Danone/Nutricia, Eisai, Grifols, Eli Lilly, Janssen, Novo Nordisk, and Roche; funding from BMBF, BZGA, DFG, DZNE, Era‐net Neuron, Horizon 2020, IMI, Innovationsfonds (GBA), and JPND; memberships for the German Association of Psychiatry (DGPPN, member of the board), German Association of Biological Psychiatry (DGBP), German Psychogeriatric Association (DGGPP), German Memory Clinic Network (DNG, Chair), and European Alzheimer‘s Disease Consortium (EADC, Chair); and served on the scientific advisory boards for German Alzheimer Association, Alzheimer Europe, and Hirnliga. Sue D. Pedersen reports consulting fees or speaking honoraria from Abbott, AstraZeneca, Bausch, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, HLS, Janssen, Merck, Novo Nordisk, Pfizer, and Sanofi; and research studies for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Medpace, and Novo Nordisk. Vanita R. Aroda reports grants and other from Applied Therapeutics, grants and other from Corcept, grants and other from Fractyl, other from Mediflix, grants and other from Novo Nordisk, other from Pfizer, grants and other from Sanofi, grants from Eli Lilly, and other from Janssen (spouse) outside the submitted work. Author disclosures are available in the supporting information.
PubMed
